2018
DOI: 10.1111/pcn.12639
|View full text |Cite
|
Sign up to set email alerts
|

Understanding the roles of glutamine synthetase, glutaminase, and glutamate decarboxylase autoantibodies in imbalanced excitatory/inhibitory neurotransmission as etiological mechanisms of autism

Abstract: The obtained data indicate that GS and GLS1 are promising indicators of a neuronal excitation and inhibition system imbalance and that combined measured parameters are good predictive biomarkers of autism.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(13 citation statements)
references
References 83 publications
(95 reference statements)
0
10
0
Order By: Relevance
“…When analysed at the microscopical level, these animals displayed a suppressed glutamatergic synaptic transmission as a result of modified presynaptic release probability, with consequent changes in synaptic glutamate concentration and postsynaptic action potential coupling (Smith et al, 2011). Because of the role that astrocytes play in the maintenance of appropriate levels of glutamate in the synaptic cleft, the glutamine synthetase (GS), an enzyme expressed in astrocytes with a critical role in glutamate synthesis, has been examined and found to be increased in the blood plasma of autistic patients (Hamed et al, 2018). Furthermore, other astrocyte-specific proteins such as AQP4 and Cx43 are altered in postmortem brains of ASD patients, thereby suggesting an underlying abnormal astrocyte-neuron communication in the pathophysiology of ASD.…”
Section: Autism Spectrum Disordersmentioning
confidence: 99%
“…When analysed at the microscopical level, these animals displayed a suppressed glutamatergic synaptic transmission as a result of modified presynaptic release probability, with consequent changes in synaptic glutamate concentration and postsynaptic action potential coupling (Smith et al, 2011). Because of the role that astrocytes play in the maintenance of appropriate levels of glutamate in the synaptic cleft, the glutamine synthetase (GS), an enzyme expressed in astrocytes with a critical role in glutamate synthesis, has been examined and found to be increased in the blood plasma of autistic patients (Hamed et al, 2018). Furthermore, other astrocyte-specific proteins such as AQP4 and Cx43 are altered in postmortem brains of ASD patients, thereby suggesting an underlying abnormal astrocyte-neuron communication in the pathophysiology of ASD.…”
Section: Autism Spectrum Disordersmentioning
confidence: 99%
“…GLS1 is the main glutamine metabolic enzyme in the brain rather than GLS2. High levels of GLSl protein were identified in many psychiatric and neurological diseases (Hamed et al., 2018 ; Huang et al., 2011 ). Microglial GLS1 deficiency could mitigate neuroinflammation in the lipopolysaccharide (LPS)‐induced depression model (Ji et al., 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…39 Among the few previous studies on ASD and anti-GAD antibody, one showed 3/20 (15%) were positive while others reported all samples as seronegative. 36,[40][41][42] These studies did not include clinical assessment. To the best of our knowledge, this is the first report investigating anti-GAD in ASD comparing classical and regressive patterns.…”
Section: Discussionmentioning
confidence: 99%